$OCGN Ocugen hopium

With the overnight share issue at a premium of 7.65 (up from 5.25) and pre-market on 8/2/21 at 8.9 the hopium on the higher time frames may not seem so far fetched. Ocugen may be the dark horse to win the Covid-19 vaccine race.